Literature DB >> 3316578

Indications for pediatric liver transplantation.

C O Esquivel1, S Iwatsuki, R D Gordon, W W Marsh, B Koneru, L Makowka, A G Tzakis, S Todo, T E Starzl.   

Abstract

Two hundred fifty pediatric (less than 18 years of age) patients underwent orthotopic liver transplantation because of end-stage liver disease and were given combination therapy with cyclosporine and prednisone. The most common indications for transplantation in decreasing order of frequency were biliary atresia, inborn errors of metabolism, and postnecrotic cirrhosis. The 5-year actuarial survival for the entire group was 69.2%. Age and diagnosis did not influence survival. Infections were the most common cause of death, followed by liver failure and cerebrovascular accident. The impact of retransplantation on survival depends on the indication. The survival is better when retransplantation is carried out after rejection than because of technical complications, and the latter has a better survival than does primary graft nonfunction. The difference in survival among these groups is statistically significant. The quality of life for 164 of 173 survivors is good to excellent; only nine children are currently experiencing medical problems. A persistent problem in pediatric transplantation is the scarcity of small donors.

Entities:  

Mesh:

Year:  1987        PMID: 3316578      PMCID: PMC3086407          DOI: 10.1016/s0022-3476(87)80053-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Factors in the Development of Liver Transplantation.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C Esquivel; S Todo; I Kam; S Lynch
Journal:  Transplant Proc       Date:  1985-10       Impact factor: 1.066

2.  Hepatic Retransplantation.

Authors:  B W Shaw; R D Gordon; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1985-02       Impact factor: 1.066

3.  OKT3 in the reversal of acute hepatic allograft rejection.

Authors:  C O Esquivel; J J Fung; B Markus; S Iwatsuki; R D Gordon; L Makowka; J W Marsh; A G Tzakis; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

Review 4.  Immunosuppression and other nonsurgical factors in the improved results of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C O Esquivel
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

Review 5.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

6.  Liver transplantation across ABO blood groups.

Authors:  R D Gordon; S Iwatsuki; C O Esquivel; A Tzakis; S Todo; T E Starzl
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

7.  Liver transplantation before 1 year of age.

Authors:  C O Esquivel; B Koneru; F Karrer; S Todo; S Iwatsuki; R D Gordon; L Makowka; W J Marsh; T E Starzl
Journal:  J Pediatr       Date:  1987-04       Impact factor: 4.406

8.  Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era.

Authors:  A G Tzakis; R D Gordon; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Transplantation       Date:  1985-12       Impact factor: 4.939

9.  Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation.

Authors:  B W Shaw; R P Wood; R D Gordon; S Iwatsuki; W P Gillquist; T E Starzl
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

10.  Role of liver transplantation in cancer therapy.

Authors:  S Iwatsuki; R D Gordon; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

View more
  14 in total

1.  FK 506 versus cyclosporine in pediatric liver transplantation.

Authors:  A G Tzakis; J Reyes; S Todo; M Green; T Ohya; A Jain; K Abu-Elmagd; M Alessiani; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 2.  Perioperative management of the pediatric transplant patient.

Authors:  R C Sachdeva
Journal:  Indian J Pediatr       Date:  1998 Jul-Aug       Impact factor: 1.967

3.  Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.

Authors:  Shuling Guo; Sheri L Booten; Mariam Aghajan; Gene Hung; Chenguang Zhao; Keith Blomenkamp; Danielle Gattis; Andrew Watt; Susan M Freier; Jeffery H Teckman; Michael L McCaleb; Brett P Monia
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

4.  Surgical technique of orthotopic liver transplantation.

Authors:  L Makowka; A C Stieber; L Sher; D Kahn; L Mieles; J Bowman; J W Marsh; T E Starzl
Journal:  Gastroenterol Clin North Am       Date:  1988-03       Impact factor: 3.806

5.  Doppler ultrasound and angiography of the vasculature of the liver in children after orthotopic liver transplantation: a prospective study.

Authors:  T Kok; P M Peeters; J M Hew; A Martijn; H A Koetse; C M Bijleveld; M J Slooff
Journal:  Pediatr Radiol       Date:  1995

Review 6.  Biliary atresia and liver transplantation: results and thoughts for primary liver transplantation in select patients.

Authors:  Riccardo Superina
Journal:  Pediatr Surg Int       Date:  2017-10-13       Impact factor: 1.827

7.  Glomerular abnormalities in children undergoing orthotopic liver transplantation.

Authors:  S E Chin; R A Axelsen; D H Crawford; Z H Endre; S V Lynch; G A Balderson; R W Strong; R W Shepherd; J R Burke; S J Fleming
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

8.  Liver transplantation for Alagille's syndrome.

Authors:  A G Tzakis; J Reyes; K Tepetes; V Tzoracoleftherakis; S Todo; T E Starzl
Journal:  Arch Surg       Date:  1993-03

Review 9.  Clinical pharmacokinetics in infants and children. A reappraisal.

Authors:  G L Kearns; M D Reed
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

10.  Alpha-1-antitrypsin phenotypes in adult liver disease patients.

Authors:  Aleksandra Topic; Tamara Alempijevic; Aleksandra Sokic Milutinovic; Nada Kovacevic
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.